# Production of α-particle emitting 211At using 45 MeV α-beam

@article{Kim2014ProductionO,
title={Production of $\alpha$-particle emitting 211At using 45 MeV $\alpha$-beam},
author={Gyehong Kim and Kwon Soo Chun and Sung Ho Park and Byungil Kim},
journal={Physics in Medicine and Biology},
year={2014},
volume={59},
pages={2849 - 2860}
}
• Published 7 June 2014
• Physics
• Physics in Medicine and Biology
Among the α-particle emitting radionuclides, 211At is considered to be a promising radionuclide for targeted cancer therapy due to its decay properties. The range of alpha particles produced by the decay of 211At are less than 70 µm in water with a linear energy transfer between 100 and 130 keV µm−1, which are about the maximum relative biological effectiveness for heavy ions. It is important to note that at the present time, only a few of cyclotrons routinely produce 211At. The direct…
6 Citations
• Biology
Targeted Oncology
• 2018
There is a significant increase in the number of clinical trials in oncology using several radionuclides such as Actinium-225 (225Ac), Bismuth-213 (213Bi), Lead-212 (212Pb), Astatine (211At) or Radium-223 (223Ra) assessing their safety and preliminary activity.
• Physics
Instruments
• 2019
The production of 97Ru, a potential Single Photon Emission Computed Tomography (SPECT) radioisotope, was studied at ARRONAX. The cross-section of natMo(α,x)97Ru reaction was investigated in the range
• Environmental Science
Journal of Radioanalytical and Nuclear Chemistry
• 2015
The goal of the present work is to give a review of developments achieved experimentally in the field of nuclear data for medically important radioisotopes in the last 3 years. The availability and
• Medicine
Nuclear Medicine and Molecular Imaging
• 2021
This year, the Korean Society of Nuclear Medicine (KSNM) is celebrating its 60th anniversary, and the therapies such as radioimmunotherapy, transarterial radioembolization, radionuclide therapy for neuroendocrine tumors, peptide receptor radion UCLA therapy, and boron neutron capture therapy are introduced.
• Education
Molecules
• 2019
The present study aims to analyze the research output on therapeutic radiometals from 2008 to 2018, with intent to quantify and identify global trends in scientific literature and emphasize the interdisciplinary nature of this research field.

## References

SHOWING 1-10 OF 36 REFERENCES

• Biology
Physics in medicine and biology
• 1996
Results suggest that meta-[211At] astatobenzylguanidine might be valuable for the targeted radiotherapy of micrometastatic neuroblastomas.
• Physics
• 2006
Radionuclide Therapy (RNT) and Radioimmunotherapy (RIT) are potentially of great interest for cancer therapy. In many therapeutic applications alpha emitters should be much more effective than
• Physics
Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine
• 2005
• Environmental Science
Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine
• 2005
• Physics
• 2008
Astatine-211 (T1/2 = 7.214 h) is an α-emitter at secular equilibrium by EC with its ultra-short-lived α-emitting daughter, polonium-211g (T1/2 = 0.516 s), with a high Linear Energy Transfer (LET —
• Physics
Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine
• 2001
• Chemistry
Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine
• 2006
• Physics